91 related articles for article (PubMed ID: 21718692)
21. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
22. High plasma levels of the soluble receptor for advanced glycation endproducts in patients with symptomatic carotid atherosclerosis.
Basta G; Castagnini M; Del Turco S; Epistolato MC; Righini P; Sangiorgi GM; De Caterina R; Tanganelli P
Eur J Clin Invest; 2009 Dec; 39(12):1065-72. PubMed ID: 19811526
[TBL] [Abstract][Full Text] [Related]
23. Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Borg DJ; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Care; 2015 Apr; 38(4):665-70. PubMed ID: 25573878
[TBL] [Abstract][Full Text] [Related]
24. Serum advanced glycation end products (AGEs) are associated with insulin resistance.
Tan KC; Shiu SW; Wong Y; Tam X
Diabetes Metab Res Rev; 2011 Jul; 27(5):488-92. PubMed ID: 21337488
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
26. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
27. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
[TBL] [Abstract][Full Text] [Related]
28. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women.
Chen L; Duan Z; Tinker L; Sangi-Haghpeykar H; Strickler H; Ho GY; Gunter MJ; Rohan T; Logsdon C; White DL; Royse K; El-Serag HB; Jiao L
Cancer Epidemiol; 2016 Jun; 42():115-23. PubMed ID: 27100837
[TBL] [Abstract][Full Text] [Related]
30. Association of α-Dicarbonyls and Advanced Glycation End Products with Insulin Resistance in Non-Diabetic Young Subjects: A Case-Control Study.
Csongová M; Scheijen JLJM; van de Waarenburg MPH; Gurecká R; Koborová I; Tábi T; Szökö É; Schalkwijk CG; Šebeková K
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432614
[TBL] [Abstract][Full Text] [Related]
31. Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis.
Fujii EY; Nakayama M; Nakagawa A
Reprod Sci; 2008 Dec; 15(10):1066-74. PubMed ID: 19088375
[TBL] [Abstract][Full Text] [Related]
32. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Piperi C; Kalofoutis A; Creatsas G
Clin Endocrinol (Oxf); 2005 Jan; 62(1):37-43. PubMed ID: 15638868
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.
Klenovics KS; Boor P; Somoza V; Celec P; Fogliano V; Sebeková K
PLoS One; 2013; 8(1):e53056. PubMed ID: 23301020
[TBL] [Abstract][Full Text] [Related]
35. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
37. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
[TBL] [Abstract][Full Text] [Related]
38. Detection of elevated N epsilon-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia.
Rüster M; Franke S; Späth M; Pongratz DE; Stein G; Hein GE
Scand J Rheumatol; 2005; 34(6):460-3. PubMed ID: 16393769
[TBL] [Abstract][Full Text] [Related]
39. Lactational performance of adolescent mothers shows preliminary differences from that of adult women.
Motil KJ; Kertz B; Thotathuchery M
J Adolesc Health; 1997 Jun; 20(6):442-9. PubMed ID: 9178081
[TBL] [Abstract][Full Text] [Related]
40. Soluble receptor for advanced glycation end products and risk of liver cancer.
Moy KA; Jiao L; Freedman ND; Weinstein SJ; Sinha R; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Hepatology; 2013 Jun; 57(6):2338-45. PubMed ID: 23325627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
